Literature DB >> 1888152

Effects of polyunsaturated fatty acids on vincristine-resistance in human neuroblastoma cells.

S Ikushima1, F Fujiwara, S Todo, S Imashuku.   

Abstract

PUFAs such as GLA (n-6) or DHA (n-3) were shown to exert antitumor activity on a human neuroblastoma cell line (NCG) and its VCR-resistant subline (NCG/VCR1, 8.6-fold resistant to VCR) in vitro. The NCG/VCR1 line had markedly decreased intracellular accumulation of [3H]-VCR and an accelerated drug efflux, compared to the NCG. The cytotoxic activity of PUFAs was correlated with the generation of MDA-like products in these cells. When VCR was added simultaneously with GLA or DHA to culture medium, the cytotoxic effect of VCR was about 2-fold enhanced, accompanied by about 1.5-2.0-fold increase of intracellular [3H]-VCR in both cell lines. Fatty acid analysis of membrane phospholipids of the NCG and the NCG/VCR1 cells treated with GLA or DHA showed an increased total PUFAs and SFAs, associated with markedly decreased total MUFAs and an inverted PUFAs/MUFAs ratio. Such phospholipid modification may have altered the membrane physical properties and enhanced the VCR cytotoxicity by increasing intracellular VCR accumulation; however, these PUFAs did not affect the drug efflux sufficiently enough to overcome completely the VCR resistance in the NCG/VCR1 cells. These results indicate that PUFAs partially alleviate the VCR-resistance in human neuroblastoma cells, not directly acting on VCR-resistance mechanism(s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888152

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Effects of carp and tuna oils on 5-fluorouracil-induced antitumor activity and side effects in sarcoma 180-bearing mice.

Authors:  Y Kimura; T Takaku; S Nakajima; H Okuda
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

2.  RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials.

Authors:  Theodore R Witte; Alexander J Salazar; Oscar F Ballester; W Elaine Hardman
Journal:  Lipids Health Dis       Date:  2010-03-22       Impact factor: 3.876

Review 3.  ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy.

Authors:  Paola Antonia Corsetto; Irma Colombo; Joanna Kopecka; Angela Maria Rizzo; Chiara Riganti
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

4.  Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.

Authors:  Rajshree L Shinde; Padma V Devarajan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Cytotoxicity of unsaturated fatty acids in fresh human tumor explants: concentration thresholds and implications for clinical efficacy.

Authors:  David E Scheim
Journal:  Lipids Health Dis       Date:  2009-12-15       Impact factor: 3.876

Review 6.  Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.

Authors:  Nicolò Merendino; Lara Costantini; Laura Manzi; Romina Molinari; Donatella D'Eliseo; Francesca Velotti
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.